Meeting of the Vaccine Safety Working Group, 15524 [E8-5892]
Download as PDF
<![CDATA[
15524
Federal Register / Vol. 73, No. 57 / Monday, March 24, 2008 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Vaccine Safety Working
Group
Department of Health and
Human Services, Office of the Secretary.
ACTION: Notice.
mstockstill on PROD1PC66 with NOTICES
AGENCY:
SUMMARY: The Department of Health and
Human Services (DHHS) is hereby
giving notice that the National Vaccine
Program Office (NVPO) will convene a
meeting of NVAC’s Vaccine Safety
Working Group. The meeting is open to
the public.
DATES: The meeting will be held on
April 11, 2008, from 9 a.m. to 5 p.m.
ADDRESSES: Department of Health and
Human Services; Hubert H. Humphrey
Building, Room 705A; 200
Independence Avenue, SW.,
Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT:
Daniel Salmon, Vaccine Safety
Specialist, National Vaccine Program
Office, Department of Health and
Human Services, Room 443-H Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201;
(202) 260–1587 or
daniel.salmon@hhs.gov.
SUPPLEMENTARY INFORMATION: NVPO has
responsibility for coordinating and
ensuring collaboration among the many
Federal agencies involved in vaccine
and immunization activities. The NVPO
provides leadership and coordination
among Federal agencies, as they work
together to carry out the goals of the
National Vaccine Plan. The National
Vaccine Plan provides a framework,
including goals, objectives, and
strategies, for pursuing the prevention of
infectious diseases through
immunizations. NVPO periodically
convenes groups to address specific
issues and topics that impact vaccine
and immunization.
The Vaccine Safety Working Group
has been established to (1) undertake
and coordinate a scientific review of the
draft Immunization Safety Office
(Centers for Disease Control and
Prevention) research agenda, and (2)
review the current vaccine safety
system.
Following the advice of the Institute
of Medicine in its report ‘‘Vaccine
Safety Research, Data Access and Public
Trust’’ (February 17, 2005), this meeting
of the Working Group is open to the
public, noting that pubic attendance is
limited to space available. Individuals
must provide a photo ID for entry into
the Humphrey Building. Individuals
VerDate Aug<31>2005
16:33 Mar 21, 2008
Jkt 214001
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person. Members of
the public will have the opportunity to
provide comments at the meeting.
Public comment will be limited to five
minutes per speaker. Any members of
the public who wish to have printed
material distributed to meeting
participants should submit materials to
the NVPO staff person designated as the
contact for additional information. All
materials should be submitted to the
designated point of contact no later than
close of business April 9, 2008. Preregistration is required for both public
attendance and comment. Any
individual who wishes to attend the
meeting and/or participate in the public
comment session should contact the
designated staff member, Daniel
Salmon, by e-mail
daniel.salmon@hhs.gov or call 202–
690–5566.
Dated: March 18, 2008.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. E8–5892 Filed 3–21–08; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–08–08AU]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Assessing Problem Areas in Referrals
for Chronic Hematologic Malignancies
and Developing Interventions to
Address Them—New—Division of
Cancer Prevention and Control (DCPC),
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description:
One of the six aims of the Insitute of
Medicine’s Crossing the Quality Chasm
report is to improve the timeliness of
care for patients. Data from Europe and
Canada, as well as single-site studies in
the United States, allude to a problem
of timely referral and diagnosis for
patients with cancer. Despite the advent
of new diagnostics and therapeutics for
patients with chronic hematological
malignancies, the size and scope of a
potential problem regarding their
referral from primary care providers to
specialists is not well-defined in the
current literature.
CDC proposes to conduct a one-time
study to collect qualitative and
quantitative information on optimal and
sub-optimal referral patterns for patients
with confirmed or suspected chronic
hematologic malignancies. Information
will be collected to identify specific
factors related to delays in diagnosis
and/or referral to appropriate medical
specialists. Information will be collected
through in-depth interviews with
hematologic cancer patients, in-depth
interviews and focus groups with
primary care providers, interviews with
specialists in hematology and oncology
in Texas, and a one-time postal survey
to a sample of primary care providers
(physicians and advance practice
nurses) in Massachusetts.
The ultimate goal is to develop tools
that will improve the awareness,
diagnosis, and referral of persons with
chronic hematological cancers by
primary care providers.
There are no costs to respondents
other than their time.
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 73, Number 57 (Monday, March 24, 2008)]
[Notices]
[Page 15524]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5892]
[[Page 15524]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Vaccine Safety Working Group
AGENCY: Department of Health and Human Services, Office of the
Secretary.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (DHHS) is hereby
giving notice that the National Vaccine Program Office (NVPO) will
convene a meeting of NVAC's Vaccine Safety Working Group. The meeting
is open to the public.
DATES: The meeting will be held on April 11, 2008, from 9 a.m. to 5
p.m.
ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey
Building, Room 705A; 200 Independence Avenue, SW., Washington, DC
20201.
FOR FURTHER INFORMATION CONTACT: Daniel Salmon, Vaccine Safety
Specialist, National Vaccine Program Office, Department of Health and
Human Services, Room 443-H Hubert H. Humphrey Building, 200
Independence Avenue, SW., Washington, DC 20201; (202) 260-1587 or
daniel.salmon@hhs.gov.
SUPPLEMENTARY INFORMATION: NVPO has responsibility for coordinating and
ensuring collaboration among the many Federal agencies involved in
vaccine and immunization activities. The NVPO provides leadership and
coordination among Federal agencies, as they work together to carry out
the goals of the National Vaccine Plan. The National Vaccine Plan
provides a framework, including goals, objectives, and strategies, for
pursuing the prevention of infectious diseases through immunizations.
NVPO periodically convenes groups to address specific issues and topics
that impact vaccine and immunization.
The Vaccine Safety Working Group has been established to (1)
undertake and coordinate a scientific review of the draft Immunization
Safety Office (Centers for Disease Control and Prevention) research
agenda, and (2) review the current vaccine safety system.
Following the advice of the Institute of Medicine in its report
``Vaccine Safety Research, Data Access and Public Trust'' (February 17,
2005), this meeting of the Working Group is open to the public, noting
that pubic attendance is limited to space available. Individuals must
provide a photo ID for entry into the Humphrey Building. Individuals
who plan to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
designated contact person. Members of the public will have the
opportunity to provide comments at the meeting. Public comment will be
limited to five minutes per speaker. Any members of the public who wish
to have printed material distributed to meeting participants should
submit materials to the NVPO staff person designated as the contact for
additional information. All materials should be submitted to the
designated point of contact no later than close of business April 9,
2008. Pre-registration is required for both public attendance and
comment. Any individual who wishes to attend the meeting and/or
participate in the public comment session should contact the designated
staff member, Daniel Salmon, by e-mail daniel.salmon@hhs.gov or call
202-690-5566.
Dated: March 18, 2008.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. E8-5892 Filed 3-21-08; 8:45 am]
BILLING CODE 4150-44-P
